CGA and gastrin-producing neuroendocrine tumor: However, there is rising evidence that the tumor localization may determine the total amount of serum levels of CgA, as patients with Zollinger Ellison Syndrome (gastrinoma) show much higher levels of plasma CgA compared to patients with GEP-NEN of the small bowel [19].